Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer

导出原文传递

翻译打印收藏纠错

作者： Ligorio, Francesca ^[1] ; Pellegrini, Ilaria ^[2] ; Castagnoli, Lorenzo ^[3] ; Vingiani, Andrea ^[4] ; Lobefaro, Riccardo ; Zattarin, Emma ; Santamaria, Marzia ; Pupa, Serenella M. ; Pruneri, Giancarlo ; Braud, Filippo de ; Vernieri, Claudio

作者单位： FIRC Inst Mol Oncol, IFOM, Via Adamello 16, Milan, Italy ^[1] Fdn IRCCS Ist Nazl Tumori, Pathol Dept, Via Venezian 1, I-20133 Milan, Italy ^[2] Fdn IRCCS Ist Nazl Tumori, Med Oncol Unit, Via Venezian 1, I-20133 Milan, Italy ^[3] Fdn IRCCS Ist Nazl Tumori, Dept Res, Mol Targeting Unit, I-20133 Milan, Italy ^[4]

关键词 HER2-Positive breast cancer Anti-HER2 resistance Metabolic reprogramming FASN CD36

发布时间 2021-09-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer letters

2021年511卷

77-87页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer

Cancer letters

相似文献

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer

Cancer letters

相似文献

Cancer letters

相关期刊

检索历史清除